René Kuijten

Bio

Dr René Kuijten, MD PhD MBA, joined LSP in early 2001 as a general partner. He serves or has served on the supervisory boards of KuDOS (UK, acquired by AstraZeneca in 2005), DNage (NL, acquired by Pharming in 2006), OctoPlus (NL, IPO Euronext 2006), Hybrigenics (F, IPO Alternext 2007), Kreatech (NL), BMEYE (NL), Nexstim (Finland) and Syntaxin (UK). René is also a board member of the NVP, the Dutch Venture Capital Association; member of the HPG representing the life sciences sector in the Netherlands; member of the valorisation advisory board of the Netherlands Genomic Initiative; member of the Netherlands Academy of Technology and Innovation; and Chairman of the ‘Stichting Steun Emma Kinderziekenhuis’. From 1992-2000, René was a senior manager at McKinsey & Company in Amsterdam, Brussels and Zurich, and co-leader of the European Pharmaceuticals and Health Care Practice. In this capacity, he advised the management boards of several multinational companies on strategy, M&A, performance improvement and restructuring. René was trained as a Medical Doctor at the University of Utrecht, Harvard Medical School and the Mayo Clinics. He completed his PhD studies at the University of Pennsylvania Cancer Center and published in medical journals as the New England Journal of Medicine and Cancer Research. He has received research awards from the World Health Organization and the International Union Against Cancer, and the Talma Eijkman Prize and the U-Gene Research Award for his scientific endeavors. He obtained his MBA degree from INSEAD in Fontainebleau, France.